New Tool Helps Identify Prostate Cancer Patients With Highest Risk of Death, Fox Chase Cancer Center Study
10/7/2011 7:53:21 AM
After a prostate cancer patient receives radiation treatment, his doctor carefully monitors the amount of prostate-specific antigen, or PSA, in his blood. An increase in PSA, called biochemical failure, is the first detectable sign of the cancer's return to the prostate. Fox Chase Cancer Center researcher have found that the time between the last radiation treatment and biochemical failure can accurately predict a patient's risk of death of prostate cancer.
comments powered by